Gene · 640
Papers2,339
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 2,339
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structure-Based Design of a Potent and Selective Covalent Inhibitor for SRC Kinase That Targets a P-Loop Cysteine. | J Med Chem | 2020 | 31935084 | PubTator, text mining | PubMed |
| Protein degradation through covalent inhibitor-based PROTACs. | Chem Commun (Camb) | 2020 | 31922153 | PubTator, text mining | PubMed |
| Maturity-onset diabetes of the young: update and perspectives on diagnosis and treatment. | Yeungnam Univ J Med | 2020 | 31914718 | PubTator, text mining | PubMed |
| Neratinib degrades MST4 via autophagy that reduces membrane stiffness and is essential for the inactivation of PI3K, ERK1/2, and YAP/TAZ signaling. | J Cell Physiol | 2020 | 31912905 | PubTator, text mining | PubMed |
| Membrane Anchoring of Hck Kinase via the Intrinsically Disordered SH4-U and Length Scale Associated with Subcellular Localization. | J Mol Biol | 2020 | 31877324 | PubTator, text mining | PubMed |
| The BET inhibitor GS-5829 targets chronic lymphocytic leukemia cells and their supportive microenvironment. | Leukemia | 2020 | 31862959 | PubTator, text mining | PubMed |
| YES1 activation induces acquired resistance to neratinib in HER2-amplified breast and lung cancers. | Cancer Sci | 2020 | 31856375 | PubTator, text mining | PubMed |
| The human fetal thymus generates invariant effector γδ T cells. | J Exp Med | 2020 | 31816633 | PubTator, text mining | PubMed |
| B Cell Tetherin: A Flow Cytometric Cell-Specific Assay for Response to Type I Interferon Predicts Clinical Features and Flares in Systemic Lupus Erythematosus. | Arthritis Rheumatol | 2020 | 31804007 | PubTator, text mining | PubMed |
| Association between the miRNA-149 rs2292832 T>C polymorphism and Kawasaki disease susceptibility in a southern Chinese population. | J Clin Lab Anal | 2020 | 31785027 | PubTator, text mining | PubMed |
| Advances in genetics toward identifying pathogenic cell states of rheumatoid arthritis. | Immunol Rev | 2020 | 31782165 | PubTator, text mining | PubMed |
| Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. | Cell Biol Toxicol | 2020 | 31758290 | PubTator, text mining | PubMed |
| Destabilization of ROR1 enhances activity of Ibrutinib against chronic lymphocytic leukemia in vivo. | Pharmacol Res | 2020 | 31726100 | PubTator, text mining | PubMed |
| Mendelian randomization analysis revealed potential causal factors for systemic lupus erythematosus. | Immunology | 2020 | 31670388 | PubTator, text mining | PubMed |
| Intratumoral spatial heterogeneity of BTK kinomic activity dictates distinct therapeutic response within a single glioblastoma tumor. | J Neurosurg | 2020 | 31628288 | PubTator, text mining | PubMed |
| Ibrutinib Potentiates Antihepatocarcinogenic Efficacy of Sorafenib by Targeting EGFR in Tumor Cells and BTK in Immune Cells in the Stroma. | Mol Cancer Ther | 2020 | 31582534 | PubTator, text mining | PubMed |
| Genetic stratification of depression by neuroticism: revisiting a diagnostic tradition. | Psychol Med | 2020 | 31576797 | PubTator, text mining | PubMed |
| The Exploration of Chirality for Improved Druggability within the Human Kinome. | J Med Chem | 2020 | 31550151 | PubTator, text mining | PubMed |
| Identification of a compound heterozygous inactivating ABCC8 gene mutation responsible for young-onset diabetes with exome sequencing. | J Diabetes Investig | 2020 | 31479591 | PubTator, text mining | PubMed |
| Neonatal diabetes caused by the heterozygous Pro1198Leu mutation in the ABCC8 gene in a male infant: 6-year clinical course. | J Diabetes Investig | 2020 | 31390154 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/640/papers?page=53